The Rationale for Radiation Oncology Data Items in STORE
The data items describing radiation oncology treatment have not been modified for several years and limited the ability to capture new and more specific data, which affect both the ability to analyze and report treatment results and patient outcomes. The new radiation oncology fields released in the Standards for Oncology Registry Entry (STORE) manual make the data more relevant and easier to capture in cancer registry databases.
The Better Data; Better Quality; Better Outcomes webinar series is for all members of the multidisciplinary care team at health care facilities that treat patients with cancer, including but not limited to:
• Cancer committee members
• Physicians (Cancer Liaison Physicians)
• Program leadership (cancer program administrators, breast program directors, breast program leaders)
• Review the rationale for the changes introduced in STORE
• Define and explain the radiation oncology terminology now in STORE
• Review common challenges and areas of confusion when coding radiation data items
- For questions about the course, please contact CoC@facs.org.
- If you have any technical questions, contact firstname.lastname@example.org.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Presenters and Disclosures
John Christodouleas, MD, MPH - No Disclosures
Dr. Christodouleas is a radiation oncologist and a nationally recognized authority on the treatment of prostate and bladder cancers. His research interest is in the use of new diagnostic and therapeutic technologies and how these can be used to optimize cancer cure rates and decrease side effects of treatments. He is an active researcher of proton therapy and MR-guided radiation therapy.
Dr. Christodouleas has written extensively about ways to optimize cancer control and quality of life for patients with cancer and has published primary research, reviews and editorials in a variety of journals including The New England Journal of Medicine, Cancer, and The International Journal of Radiation Oncology*Biology*Physics. He has authored more than 20 book chapters on the care of cancer patients and is coeditor of one of the leading textbooks in radiation oncology.
He was the University of Pennsylvania’s primary investigator to the Proton Collaborative Group and quality co-chair of the National Radiation Oncology Group Adjuvant Radiation trial for bladder cancer and is presently co-primary investigator for the MOMENTUM Study, an international observational cohort study of MR-guided radiation therapy.
Dr. Christodouleas has a strong interest in creating better linkages between the radiotherapy and cancer registry community. Since 2015, he has served on the Commission on Cancer’s Radiation Oncology Working Group, which manages the radiation data items in the STORE Manual and the National Cancer Database.
A Certificate of Completion will be awarded for this course.
1 continuing education credit for #2020-115 will be provided from National Cancer Registrars Association (NCRA).
ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437, for 1 contact hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 CE Contact hours
- 1.00 Certificate of Completion